Compare Alcon AG (ALC) vs EOG Resources Inc (EOG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs EOG Resources Inc — how do they compare? Alcon AG trades at $66.93 (market cap $32.69B), while EOG Resources Inc trades at $137.37 (market cap $71.66B). The key difference: EOG Resources Inc is far larger — about 2.2× Alcon AG's market cap, and EOG Resources Inc pays the higher dividend (3.03%). Which is the better fit depends on your goals.
| ALC | EOG | |
|---|---|---|
Market Cap | $32.69B | $71.66B |
Sector | Health | Energy |
52-Week High | $92.22 | $149.89 |
52-Week Low | $62.02 | $101.78 |
Enterprise Value | $36.28B | $76.12B |
Dividend Yield | 0.54% | 3.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
EOG Resources trades at $134.54, up 2.88% today, with a bearish technical signal but strong fundamentals including a P/E of 12.72 and net income margin of 23.39%. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected August 5, 2026. Recent news highlights strong free cash flow potential and shareholder returns, while analyst consensus is a Buy with a $157 price target.
The outlook for EOG is positive due to robust profitability, consistent earnings beats, and favorable oil price trends. Key risks include volatile energy markets and high capital expenditures. With no sell ratings from analysts and a price target implying 17% upside, the stock presents a compelling opportunity for value-oriented investors despite near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →
